Michael Rypl is the Managing Director of Healthcare Investment Banking at Dawson James Securities, Inc., a position he has held since September 2023. Based in the United States, Michael brings extensive experience in the healthcare investment banking sector.

Prior to joining Dawson James Securities, Inc., Michael served as Vice President of Healthcare Investment Banking at Ladenburg Thalmann from January 2017 to September 2023. His career also includes roles as Associate Director at Oppenheimer & Co. Inc. and Vice President positions at Maxim Group, NOBLE Capital Markets, and POLARIS INVESTMENT PARTNERS.

Michael's extensive background in investment banking, particularly within the healthcare sector, underscores his expertise and leadership in the field.